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Introduction: 
In this study, the ease and flexibility with which 
computers can interface with medical technology is ex¬ 
plored. Specifically, a procedure is described where 
echocardiograms are analyzed and, in combination with 
additional patient data, yield information pertinent to 
ventricular function. The focus of the study is a new 
intravenous hypnotic, etomidate. Its effect on left 
ventricular function will be compared to that of thiopental. 
The computer by no means replaces the reader whose 
expertise remains an Integral part of echocardiographic 
interpretation. It merely assists to make the analysis 
as simple and as rapid as possible. 
There have been recent advances in the automatic 
1,4 
analysis of echocardiograms. The advantage lies in 
the consistency of the method of analysis. However, the 
computer, once programmed, is inflexible. It cannot make 
adjustments for unexpected errors unless it has been 
specifically programmed to do so. 
Due to its non-invasive properties, ultrasound is 
a valuable tool for assessing the functional status of 
the heart. The alternative methods include cardiac 
2,3 
catheterization and isotope imaging, both of which 
are invasive procedures, Nuclear imaging is currently 
used in the calculation of ejection fractions and 
2 
• 
cardiac outputs and,although less invasive than cath¬ 
eterization, it still involves an injection of a radio¬ 
active material and requires suitable precautions. 
The frequency with which a non-invasive procedure 
can be used to take repeated measurements makes i"i ideal 
for interfacing with a computerized system. The large 
volume of data that is generated makes a computer 
necessary for both analysis and storage. 
The major task of this study will be discussed in 
the section on methods. 
The Etomidate Study will be a test case for the 
computerized system^ 
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Background: 
The Use of Echocardiograms in Determining Left Ventric- 
ular Functions: 
Notwithstanding the of echocardiograms, 
we must establish the reliability of quantifying left 
ventricular functions by this method. Ultrasound signals 
are rapidly attenuated by air filled structures. Therefor 
due to surrounding lung, the "window" of ultrasound ac¬ 
cess to the heart is very small. Information obtained 
from the M-_mode echoes is a onevdimensional signal that 
varies with time. Only one diameter of the left ventric¬ 
ular cavity can be obtained and must be extrapolated 
to a three-dimensional volume. This process requires 
a number of assumptions, but it has been studied over 
the past few years and has been proven feasible. 
A more precise method for studying left ventric¬ 
ular dimensions is the real-time scanner which images a 
two-dimensional plane through the long axis of the left 
ventricle. This two-dimensional view of the ventricle 
allows for the approximation of the third dimension. 
To determine accurate volumes from M-mode echoes 
a regression formula is employed to correct for the 
geometrical assumptions made for the shape of the left 
ventricle. The regression equation can be calculated 
by comparing ultrasound readings with left ventricular 
, 
volumes obtained from thermodi.lut.ion ( or dye dilution ) 
cardiac outputs or from angiographic results. 
A major clinical problem is the determination of 
volumes in the diseased heart Since most patients 
requiring left ventricular function studies have dis¬ 
eased hearts, it is important to determine how variations 
such a wall motion abnormalities interfere with echo 
results. Valvular regurgitation also presents a specific 
problem. Stroke volumes may be accurate, but echo pre¬ 
diction of cardiac output will be erroneously high due to 
regurgitation of a portion of the ejected blood. It has 
also become apparent that heart rate and systemic arterial 
pressure must be considered in the evaluation of cardiac 
5 
functions by echocardiogram 
Several studies have shown good correlation of 
ultrasound and angiographic calculations of left ventric- 
6 
ular volumes. Fortuin et al measured left ventricular 
dimensions and volumes in 27 patients with various cardiac 
abnormalities. He compared ultrasound measurements with 
those obtained by biplane angiography and found good 
7 
correlation. Pombo et al had excellent correlation 
between ultrasound and angiography in 27 patients. Feigen 
8 
baum et al also found significant correlation between 
ultrasound measurements and angiography measurements at 
end-systole and end-diastole in 42 patients. Belenkie 
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9 
et a 1 studied 40 patients with cardiac disease and used 
18 patients with technically excellent results. He 
stated that there was good correlation between angio¬ 
graphy and ultrasound. 
A fault of these preceding studies is that the 
ultrasound and angiographic measurements were not made 
10 
simultaneously. Linhart et al described some of the 
defects in the studies performed to assess the reliability 
of echocardiography. He states that four assumptions 
must be true before translating the minor axis into a 
three-dimensional volume: " (1) that the longitudinal 
cross-sectional geometry is known and is the same in 
all persons (present thinking assumes it to be an 
ellipse); (2) that its three-dimensional shape is this 
two-dimensional figure rotated on its minor axis; 
(3) that these two conditions are true in both systole 
and diastole, in volume overloaded and in pressure 
overloaded states, in ischemic heart disease and in 
primary myocardial disease; and (4) that the major axis 
of the left ventricle is constant or is a constant 
known multiple of the minor axis in all patients in 
systole and in diastole,” He then states that none of 
these assumptions is true, and points out that in each 
of the studies comparing ultrasound and angiography a 
different regression equation was employed. If the 
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results were combined, the correlation would not be 
reliable. 
Linhart's critique is too severe. The geometric 
limitations are overcome by employing a regression 
equation. Each previous study, examined individually, 
is a valid study. Linhart does state that one-dimensional 
echoes are appropriate in following the clinical course 
of a single patient. This is important in the Etomidate 
s 
Study because individual patients are studied at re¬ 
peated intervals during the induction of anesthesia. 
Valuable information is derived from the trends observed 
in each patient. 
1 1 
Teichholz et al retrospectively studied 100 
left ventriculograms in the RAO projection and derived 
a regression formula for volumes using the minor axis. 
They then studied 24 patients, 12 with asynergy and 
12 controls, using angiography and echocardiography. 
The variability in his results suggest possible problems 
in the use of M-mode echocardiography for the calculation 
of ventricular volumes in patients with coronary artery 
disease and possible left ventricular asynergy. 
• 15 
In a later study, Teichholz et al showed that 
B-scan ultrasonography ( gated two-dimensional imaging ) 
can overcome the limitations associated with asynergy. 
When compared with angiography,1 ejection fractions had a 
I 
correlation of r = . 9 2 in normal patients and r = . 8 7 in 
patients with left ventricular asynergy. 
12 
Ludbrook et al also studied one-dimensional 
wall motion abnormalities and found that although 
volume calculations may be in error^ the mean velocity 
of circumferential fiber shortening remains a reliable 
index of left ventricular performance. 
Acute alterations in heart rate and systemic arter¬ 
ial pressure are known to influence echocardiographic 
measurements of left ventricular performance. Hirsh- 
5 
leifer et al showed the impact of this effect on the 
normalized mean velocity of circumferential fiber short¬ 
ening, but there have been no studies to delineate the 
effects of ventricular dimension measurements. 
13 
An excellent study by Popp and Harrison compares 
echocardiographic stroke volumes in 30 patients with 
volume readings obtained simultaneously at catheterization 
using the Fick principle. This experiment acquired 
simultaneous data and is thus quite reliable. The 
correlation coefficient found between the two studies 
was r=,966. In the same paper the severity of valvular 
0 
regurgitation was estimated by comparing the forward 
stroke volume determined by the Fick method with the 
total left ventricular stroke volume determined by the 
echocardiographic method. This is a useful comparison. 
-8- 
1 
It can be done routinely during cardiac catheterizations. 
14 
Fortuin et al showed the reproducibility of 
echocardiographic measurements in evaluating a wide 
variety of ambulatory patients. He studied five groups: 
(1) normal: (2) mitral stenosis; (3) compensated volume 
overload; (4) idiopathic hypertrophic subaortic stenosis; 
and (5) congestive heart failure. Although no angio¬ 
graphic correlations were made, reliable patterns in volume 
measurements in each of the five categories were deter¬ 
mined . 
Although there are limitations in the use of ultra¬ 
sound for volume calculations, it appears that they can be 
overcome if they are understood. If only technically good 
ultrasound examinations are analyzed in cases where the 
anatomical landmarks are well defined, and allowance is 
made for abnormalities that interfere with interpretations, 
the volumes derived from the minor axis will be cliically 
reliable. 

Digitizers: 
Interfacing a computer with a digitizer permits 
fast and accurate analysis of graphic information. This 
type of input device has proven useful in areas of 
medicine that require quantification of linear distance 
in diagnostic tests. Using this graphic input, total 
lung capacities can be calculated from PA and lateral 
x-rays and electrocardiograms can be analyzed. The 
area under the curves of serum electrophoresis spikes 
can be quantified. Graphic information such as the 
monthly temperature chart can also be stored. 
There are many ways of inputting graphic information 
and many devices developed for this purpose. A terminal 
with a cathode ray tube makes use of ''cursor lines" to 
establish the coordinates of a point. The position of 
both lines is set by hand and is a clumsy process. 
Another device is a "light-pen" which responds to light 
from a television tube, and electronically records the 
coordinates, but the instrument is relatively inaccurate. 
The common drawback of these methods is that they 
employ cathode ray tube displays and cannot analyze 
information on paper. 
The "tablet" and the "sonic digitizer" are two 
instruments that are capable of dealing with paper 
printouts in a rapid and efficient manner. Both are 

accurate to one one-hundredth of an inch. The "tablet" 
uses magnetic fields and is very useful in two dimensions. 
The "sonic digitizer" is just as useful and has both 
advantages and limitations. A spark is emitted upon 
depression of the pen point and the sound is received 
by two microphones at right angles to one another, repre¬ 
senting x and y axes. Since the spark is several 
millimeters away from the penpoint, the pen must always 
be held with the same orientation to ensure consistency. 
Spatial coordinates are established by the speed with 
which the sound of the spark reaches each microphone. 
* 
Therefore anything which obstructs the path, e.g. ex¬ 
traneous paper or a hand, will impede the signal and 
increase the reported distance. Nevertheless, the device 
is convenient because the microphones can be mounted 
on any surface, including the face of a cathode ray tube. 
-11- 

Materials and Methods: 
Materials : 
The input device to be used is the Science Accessories 
Corporation's NT-501 digitizer, also known as the "graf- 
pen", It is an ultrasonic digitizer with an accuracy of 
one one-hundredth of an inch at the proper temperature 
and humidity. The pen can be set to input points into a 
computer individually,or continuously as a line is being 
drawn. The machine can be adjusted to acquire point co¬ 
ordinates at the rate of one every five seconds or as 
fast as 60 pulses perfsecond, depending on the information 
capacity of the terminal. A built-in microprocessor is 
able to calculate the area inside a closed curve. This 
is useful in reading real-time echocardiograms. 
The data obtained is printed out on a teletype and 
transmitted over a phone link to a computer. The computer 
used in this study is an IBM 371-58 with a four megabyte 
capacity. A time sharing system is employed, and many 
operators can use the computer simultaneously. The 
computer divides its time equally among users, continuously 
cycling its attention to each operator for a very brief 
period of time. For this reason each data point must 
be verified, and a Deckwriter II terminal is used to -: 1 t 
send the initial instructions necessary to run the computer 
program. 
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The programming language is Fortran IV. 
Communication between the computer and the input/output 
devices is done by a telephone link using an Andersen- 
Jacobson interface which converts acoustic messages sent 
by the computer into electrical signals, and converts 
electrical signals created at the input device into 
acoustic signals that can be transmitted across phone 
lines. Therefore, this program does not require a private 
computer. The computerized analysis is accessible to 
any person with an input device and a phone. 
The source of the data analyzed is the standard 
tf 
ultrasound M-mode printout. This represents a one¬ 
dimensional view of the heart and its internal structures 
as they vary in position with time. Distances between 
structures can be accurately gauged by comparing them 
with one-half second time markers and one centimeter 
distance markers. In addition an electrocardiogram is . 1 
displayed so that the contractile state of the heart can 
be assessed. 
i -13- 

Methods r 
Introduction; 
To use the digitizer efficiently, a work board is 
designed to set aside separate areas for control commands 
and the actual input of data. 
The area for control commands is called a "menu" 
and consists of the parameters, e.g. left ventricular 
end-diastolic dimension, that are necessary for the 
study. The purpose of the menu is to simplify the analysis 
procedure. One merely designates a parameter on the menu 
instead of typing it ifn at the terminal. Thus one need 
never leave the digitizer while the program is running. 
The total surface area is fourteen inches by fourteen 
inches, or 196 square inches. Thirty square inches, or 
three by ten inches is set aside for the menu. Each 
function control resides in a box measuring one square 
inch and is bounded by a set of line segments (see p.23) . 
When a function on the menu is selected the computer 
knows that the point is within the borders of the menu 
and will determine which function has been selected. The 
operator may then proceed to input the data related to 
that function. When he has entered a sufficient number 
of trials, he need only select another function listed 
in the menu. The computer then prints out the results 
of its analysis and readies itself for the input of data 
-14 r 
. 
related to the function just selected. This process 
continues until the entire echocardiogram has been 
analyzed. 
Numerical information such as the patient’s blood 
pressure must also be entered in this study. To type 
it in directly would defeat the purpose of the digitizer. 
The ideal solution lies in utilizing the space already 
provided by the menu in much the same way as one uses 
upper and lower case on a typewriter. Ten of the menu 
boxes are assigned the numbers zero through nine. Another 
box is set aside for fhe function VBP". When this 
function is selected, a subprogram is called up that 
reads the systolic and diastolic blood pressures from the 
menu as if they were being entered directly from a type¬ 
writer, After this task has been completed, the sub¬ 
program relinquishes control to the main program, and 
the menu functions are interpreted as before. This 
process can be extended to include other types of numer¬ 
ical input. 
The interactive aspects of the system are useful 
in eliminating sources of error and in ensuring that the 
operator follows procedures correctly. "Interactive" 
refers to the ability of the operator and the computer 
to communicate with one another while the program is 
runningThe computer, by printing instructions on the 
i 
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teletype, asks the operator to do the proper standardi¬ 
zations before entering data. It also prints out each set 
of coordinates to verify that it has received the infor¬ 
mation. This is an important consideration in a time 
sharing system where the computer is not totally committed 
to your program. The operator must wait until the com¬ 
puter has received the data before entering the next set 
of data, If programmed correctly, the computer can tell 
the operator whether he has made an error, for example, 
entering a data point where he is supposed to be entering 
a function from the menu. 
When an analysis is completed the computer prints 
the results. One can obtain a printout, with an impression 
if desired, that can be entered directly into the patient's 
records. This saves immeasureable time over hand cal¬ 
culations which must be organized and typed. Here, when 
the data has been entered, the analysis is complete in its 
final form. 
The format of the printout names the function and its 
value and lists how many samples were averaged to arrive 
at this value. For calculated functions, values are printed 
out in sentences. An impression of the patient's 
cardiovascular status can then be typed at the bottom of 
the page. 
\ 
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Functions Defined: 
The following functions are found on the menu: 
1. RVAWD: right ventricular anterior wall thickness in 
diastole 
2. RVAWS: right ventricular anterior wall thickness in 
systole 
3. RVDD: 
4. SEPD: 
5. SEPS: 
6. LVESD: 
7. LVEDD: 
8. LVPWD: 
right ventricular cavity dimension in diastole 
septal thickness in diastole 
septal thickness in systole 
left vefuricular cavity dimension at end-systole 
left ventricular cavity dimension at end-diastole 
left ventricular posterior wall thickness in 
diastole 
9. LVPWS: left ventricular posterior wall thickness in 
systole 
10. LAS: maximum left atrial cavity dimension 
11. AOS: aortic diameter measured at the same time as LAS 
12. PA: pulmonary artery diameter at end-systole 
13. MVDE: mitral valve D to E slope 
14. TVDE: tricuspid valve D to E slope 
15. LENGTH: length calibration 
16. HAFSEC: distance of paper travel in one half second 
17. LVPEP: left ventricular pre-ejection period measured 
from onset oft Q-wave to opening of aortic valve 
18. LVET: left ventricular ejection time; i.e. the time 
-17- 
• 
that the aortic valve stays open 
19. RVPEP: right ventricular pre-ejection period measured 
from the onset of the Qrwave to the. opening of the pul¬ 
monic valve 
20. RVET: right ventricular ejection time measured from 
the opening to the closing of the pulmonic valve 
21. HR: heart rate; done by entering several R-R intervals 
22. MVEF: mitral valve E to F slope 
23. TVEF: tricuspid valve E to F slope 
24. AREA: trace area of two-dimensional left ventricular 
section from the real time output 
25. LONGAX: determine the longest axis of the two-dimen¬ 
sional image 
26. END: ends the input, and the program proceeds to 
do its calculations and final printout 
27. BP: initiates the blood pressure subprogram 
28. BSA: initiates the body surface area subprogram 
> 
The computer calculates several values related to the 
information it has just received above. They are: 
LVEDV: left ventricular end-diastolic volume using the 
3 
Meyer formula (LVEDV=-19.12+14.58 x LVEDD + .62(LVEDD) ) 
I.VESV * left ventricular end-systolic volume using the 
Meyer formula 
EF: ejection fraction (LVEDV-LVESV)/LVEDV 
FS ! fractional shortening (LVEDD-LVESD)/LVEDD 
vl 8 
• 
VCF: velocity of mean circumferential fiber shortening; 
FS/LVET 
LVPEPET: LVPEP/LVET 
RVPEPET• RVPEP/RVET 
LVPEPC(Weissler): LVPEP + 0.6 x HR 
RVPEPC(Weissler): RVPEP + 0.5 x HR 
LVETC(Weissler): LVET + 1.6 x HR 
RVETC(Weissler): RVET + 1.5 x HR 
LAAO: LAS/AOS 
SPLPWD: SEPD/LVPWD 
# 
WSDS: LVPWS/LVESD 
LVCAVP: estimated left ventricular cavity pressure: 
WSDS x 225 
SYSGRAD: estimated systolic gradient: LVCAVP-BP 
SV: stroke volume: LVEDV~LVESV 
COs cardiac output: SV x HR 
Cl< cardiac index: CO f BSA 
mean BP{ BP(diasto1e)+1/3 x (BP(systo1e)-BP(diasto1e)) 
Ventricular Volume (from real time): 
(8 x AREA2)/(3 x TT x LONGAX) 
-19- 

Procedure for Data Input: 
The Etomidate Study is a study limited to left 
ventricular function and deals primarily with cardiac 
indices. The functions that are included are LVEDD, 
LVESD, HR, B SA, LVEDV, LVESV; SV, CO, Cl, and mean BP. 
To begin the analysis the M-mod e paper printout is 
laid flat across the work board parallel to the x-axis. 
The menu is at the top of the workboard. 
• The operator then calls the computer on the telephone, 
places the receiver in the carrier box, logs on to the 
computer and runs the 'program. The computer asks the operator 
to initialize the workboard. The operator enters the 
( 0,0 ) coordinate as the point in the upper left corner 
of the workboard. Under program control the operator then 
enters the LENGTH function and inputs several pairs of 
data points. Each pair of points represent the calibration 
for one centimeter distance in the patient's heart. After 
each point is selected, the operator must wait briefly for the 
computer to repeat the coordinates to ensure that it has 
been entered. The operator then selects the HAFSEC 
function and inputs pairs of half-second marks along the 
x-axis.. If the paper speed is 50 mm/sec, HAFSEC will 
equal 25 mm. The echocardiogram has now been standardized 
and is ready for analysis. 
The heart rate function is selected and three pairs 
-20- 

of R-R intervals are entered. More pairs can be entered 
if the rhythm is irregular. When sufficient pairs have 
been entered, the next function, LVEDD , is selected. 
At this time, the heart rate is calculated using the 
average R-R interval, and it is immediately printed 
along with the number of pairs evaluated. 
LVEDD has already been selected and the computer is 
waiting for the data. The operator must locate the 
section of the echocardiogram where the acoustic beam 
has passed through the mitral annulus and clearly shows 
the borders of the left ventricular cavity in end- 
# 
diastole. The ventricle is at end^diastole as it is 
depolarizing, so a cursor on the work board is positioned 
at the QRS wave parallel to the y-axis and the pair 
of left ventricular border points are entered for three 
separate beats. When the next function, LVESD is selected, 
the computer prints out the average LVEDD value and the 
number of trials averaged. 
LVESD is analyzed in exactly the same way except 
that end-systole is chosen to be the time at which the 
ventricular borders are in closest approximation. 
When the BP or BSA functions are selected, subprograms 
are run that read number values directly from the digitizer 
as previously described. 
When the function END is selected, the computer 
-21- 

ceases to interact with the operator and proceeds to 
perform the final calculations and the formalized 
printout. 
The entire process just described lasts approximately 
four minutes and results in a typewritten list of 
ventricular functions. If performed manually, even with 
a hand calculator, this process would take from fifteen 
minutes to half an hour. 
22 
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Cardiovascular Effects of E tomidate and Thiopental: 
Thiopental is a widely used drug in the induction 
of anesthesia. Because of the cardiovascular changes 
that occur during induction, there is a search for a 
more benign intravenous agent. The effects of thiopental 
16 
after conventional pre-anesthetic medication include: 
(1) a decrease in cardiac output; (2) an increase in 
total calculated peripheral resistance; (3) no change or 
a fall in mean arterial blood pressure - this is thought 
to be caused in part by histamine release; (A) an increase 
or no change in heart rate; (5) a decrease in cerebral 
blood flow with a marked fall in cerebrospinal fluid 
c 
pressure . 
Etomidate is a new intravenous hypnotic agent 
developed in 1971 which appears to have less of a 
depressant effect on the cardiovascular system, 
It has been compared with thiopental in dogs and is 
18 
found to be superior in all categories measured. There 
was a 60% increase in heart rate with thiopental and less 
than a 10% increase with etomidate. Thiopental decreased 
the stroke volume by 40% while etomidate had no effect. 
The mean arterial pressure remained stable in both 
etomidate and thiopental subjects, The cardiac index 
fluctuated with thiopental, increasing 30% in the first 
minute,1 dropping to 10% below the control by the third 

minute, and then stabilizing at control values. Etomidate 
values remained within 10% of the control. 
In a study on human volunteers it was shown that 
17 
etomidate does not release histamine. This may contribute 
to its favorable results. 
Patients with stage III and IV cardiac valvular 
19 
disease were studied at surgery and it appears that 
etomidate produced only small effects on hemodynamics 
with less of an increase in myocardial blood flow and 
consumption of oxygen by the myocardium. Thus etomidate 
may be advantageous for induction of anesthesia in 
P 
cardiovascular risk patients. 
In addition to its benefits over thiopental, etomidate 
was also found in these studies to be superior to metho- 
hexital, propanidid, althesin, piritramid, and ketanin. 
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Etomidate Study; 
Digitizer Accuracy: 
The accuracy of the digitizer was established 
before analysis of the data. Much of the input data 
are lengths of one inch, so this was chosen as the 
standard measurement. Twenty trials of measurement 
of ruled inch marks were performed parallel to the 
y-axis, and twenty trials were performed paralled to 
the x-axis. In both cases all values were within 
one one^hundredth of an inch of the standardized 
measurement . 
-26 

* 
Protocol Information: 
Twenty norma1 patients were selected from the ranks 
of preoperative candidates. Half were induced with 
etomidate and the other half were induced with thiopental. 
Six of the echocardiograms were technically unreadable, 
due to interference from the chest wall and lungs. 
Post-premedication echodimensional values serve as 
the control values and are compared with values obtained 
the prior day and values obtained one, two, and three 
minutes after administration of the induction agent. 
In analyzing thef cardiac indices and ejection 
fractions, it is important to follow the trends within 
each patient study and not just the absolute values. 
Because of the problem, already discussed, of using 
regression formulas from other studies, it will be 
necessary to obtain standardizations for each patient at 
a later date. This will consist of a simultaneous 
cardiac output using the Fick principle and echocardiography. 
* see Appendix B 
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Discussion: 
The results consist of an analysis of heart rate, 
mean blood pressure, ejection fraction, and cardiac 
index. Certain patterns were noted. The cardiac index 
and ejection fraction fluctuate unevenly with thiopental. 
Patients with etomidate follow a more stable pattern for 
all values measured. This is in agreement with the 
findings of previous studies. The standard error of the 
mean is universally smaller with the etomidate patients. 
However these results are somewhat inconclusive at 
this time and it will^be necessary to derive accurate 
o 
regression formulas and reapply them to the data. 
The corrected results will lend significance to 
the trends observed in this study. 
-28- 
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Conclusion: 
In summary, this program takes measurements, performs 
calculations and produces a printout without requiring 
the operator to write or type. The entire procedure 
takes place through the selection of coordinates with 
a pen on a digitizer surface. 
It is the programmer's responsibility to design a 
program that can be implemented by a person who knows 
nothing about computers. There are large volumes of 
data which will have to be analyzed by doctors and 
technicians. They will rely on a method that is simple, 
rapid and accurate. 
Although the actual measurements and calculations 
performed by the computer are simple, the difficulty lies 
in conceptualizing the best method for interacting with 
a computer. The algorithm in this study is designed to 
ask questions at the appropriate time, display error 
messages where needed, and make use of a menu in an 
efficient way. The increased complexity of the computer 
program makes the analysis simpler for the operator. 
The ideal use of such a method is to allow several 
operators to utilize the same program from separate input 
devices. This eliminates the need for a separate micro¬ 
processor for each type of analysis. Many programs can 
be written for many types of analysis and can be shared 
by people with digitizers. In this way, operators need 
-33- 

purchase only input devices, e.g. isotope scanners for 
ejection fractions or digitizers for x-rays and 
ultrasound, thus minimizing equipment cost. 
e 
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Appendix A 
Computer Programs 
# 
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O L 
C 
O 
c 
I 
G 
00010 
00020 
00030 
00040 
00050 
00060 
00070 
000S0 
00090 
00100 
00110 
00120 
00130 
00140 
00150 
00160 
00170 
00180 
00190 
00200 
00210 
00220 
00230 
00240 
00250 
00 
2/ 
00230 
00290 
00300 
00310 
00320 
00330 
00340 
00350 
00360 
00370 
0 03 8 0 
00390 
00400 
00410 
00420 
00430 
00440 
00450 
00460 
00470 
00430 
00490 
00500 
r lvssD y LVEDD ? LVPWD r LOEWS r LAS y MODE ? L-VPEP t JA'El * 
L_ p £ p.E T , L. A A 0 v L V C A 0 P >■ L 0 L D 0 t L 0 N 5 i-i X r L 01-... I- C L ✓ L i C_ 
708 
101 
■ POINTS' ) 
HIAT THE ORIGIN IS AT <1f1> 
260 
00 70 
C 
C 
C 
C 
C 
C 
C 
C 
700 
INTEGER P 
REAL LENGTHrLVE 
CMVEIF y LOG.SO y L_PEP.i_ i ?..m .  — 
C 0 M M 0 N N y L. E N G T H y X S T A1LD y Y S T A N D r A 0 G X y A 0 G Y y P t A* > 
READ IN FROM TERMINAL 
INTEGER SYSDP y DIASBP 
SYBBP-0 
DIASBP=0 . . • 
PRINT 708 
FORMAT (' INPU 
STANDARDIZE SO 
READ 101y X y Y 
PRINT .JP01 yXy Y 
FORMAT (F6♦2 y F7 
X S T A M D X -1 ♦ 
Y3T AND-Y-i. 
LENGTH IS THE YAXIS 
INITIALIZE IT TO 1, 
LENGTH"1♦ 
READ IN THE FIRSt POINT - " ' 
READ 101 y X#? Y ... ..... - ., - 
UE^SEf/up'a's X 10 INFORMATION GRID WITH AN 
.1,1 AND THE.UPPER YDORDER AT 4. UNDER Trllo 
ANY POINT BELOW Y-4 IS CONSIDERED A CON) ROL- 
.AND NOT DAT A * THE X AND t OriLLJ.»o ARE RE-..,L) 
SU THAT ANY XyY OALUE WITHIN A BOX OP 
t) 
LENGTH CORRECTION TO 1 CM* 
AT 
2 y 1 
c 
G 
C 
C 
ORIGIN 
SYSTEM 
COMMAND 
TO INTEGER 
BORDERS 1y1 
0,0 y■[LL BFR RESET TO 1 r 1 ♦ NCW STANDARDIZE 
X.AND Y, THE. TABLET RECORDS IN INCHES SO UIE HILL HAVE 
TO CONVERT LATER TO CENTIMETERS _-— - 
•X=X~XSTAND . - 
Y = Y-YSTAND , > -. - 
9999 C0NTINUE .;___‘---'-~- 
NEWX=X 
NEWY-Y -— 
: IF NEWY IS GREATER THAN 3y 
IF (NEWY♦GT« 3) PRINI 703 
FORMAT (' ERROR"> 
IF (NEWY.GT.3) GO TO 700 
SET UP THE GRID_S0 THAT EACH 
ONE NUMBER(NEWX) 
( NEWY « E Q ♦ 2 ) NEWX= NEUXT10 __ 
( N E U Y . E 0 ♦ 3 > N E W X - N E W X i 2 0 
(NEWX.EQ.26> GO TO 0388 
uauf DIVIDED OUR DATA INTO 3 SETS? THOSE 
ONLY Y VALUES? THOSE NEEDING ONLY X VALUEa v 
THOSE NEEDING DOTH * ^ , r, rnr. TMF„F 
rr.Tfic 1-15 NEED ONLY Y VALUES * P-1 FOR rUEoE 
Gil I DS i s-21 NEED ONLY X VALUES = 1-2 FOR THESE 
GRIDS 22-♦*♦ NEED BOTH * P-3 I 0K THESE 
703 
IT'IS NOT A CONTROL COMMAND 
BOX IS ASSOCIATED WITH 
IP 
IF 
IF 
WE 
WHICH 
AND 
NEED 

© 
00510 
00520 
00530 C 
© 
00540 
00550 
00555 
0 
00560 
00570 
005 El 0 c 
00590 c 
00600 c 
Q 00610 C 
a 
00620 
00630 
00640 
00650 c 
00660 70 
© 00670 
Q 
00680 
00690 
00700 7.1 
0 
00710 
00720 
00730 
00740 
00750 
% 
c 
0 00760 c 
00770 c 
00780 1 
0 00790 c 
00800 
00810 801 
© 00S20 
00830 2 
00340 C 
© 00850 
00860 802 
00870 
© 00880 3 
00890 C 
© 
00900 
00910 803 
00920 
00930 4 
© 00940 C 
00950 
00960 CO
 
o
 
0 00970 
00980 5 
00990 c 
© 01000 
IF (N F W X . L E , i 5) G 0 T □ 7 O” 
IF(NEWX«LE,21 ) GO TO 71 
AT THIS POINT WE ARE LEFT WITH GRIDS 22-26 
IE(NEWX * EQ.24) GO TO 24 
IF (N E W X . E 0 , 2 7 ) C A L L ' E L 0 0 D ( X S T A N D y Y S T A N D ? S Y S B P , BIA S B P) 
IF(NEWX♦EQ♦28) CALL B0DY(XSTANDyYSTAND,BSA) 
P-3 
CALL SUM 
SLIM RETURNS A LENGTH OF A LINE SEGMENT AUER AGED OVER 
S E V E R A!... T RIA L S * IT A L S 0 R E T U R N S I H E NIJ M B E R 0 ,rr T RIA L 3 * 
WE TAKE THIS INFO AND HANDLE IS ACCORDING T 
TO Tr|E MANNER SPECIFIED BY THE CONTROL GRID COMMAND, 
IF (N, ELKO) GO TO 9999 
N E W X - N E W X -- 21 
G 0 T 0 (22 r 2 3 v 2*1 r 2 5 ) ? N E W X 
WE HANDLE THE INFO FOR P--1 AND P=2 IN THE SAME FASHION, 
P=1 
CALL SUM 
IF(N,EQ,0)G0 TO 9999 
GO TO ( I y 2 y 3 y 4 y 5 y 6 y 7 y El y 9 y 1 0 y 1 1 y 12 v 1 3 y 1 A r 15 > y NEWX 
P = 2 
CALL SUM 
IF(N,EQ,D)GO TO 9999 " 
' N E W X - N E W X - It'S 
G 0 T 0 (16 y 17 y 10 r 19 y 2 0 y 21 ) y N E W X 
NOW WE WILL PRINT OUT THE UALLIES ACCORDING TO GRID 
SPECIFICATIONS 
1 IS THE CONTROL GRID VALUE FOR RVAWD 
RVAWD-AVGY 
RIGHT VENTRICULAR ANTERIOR WALL IN DIASTOLE 
PRINT SOIyRVAWDyN 
F0RMAT(' R VAWD ='yF7♦2 y 7 AVE RA G ED 0V ER7 y13 y 2X y 7 TRIALS') 
GO TO 9999 
RVAWS=AVGY 
RIGHT VENTRICULAR ANTERIOR WALL IN SYSTOLE 
PRINT S02 y RVAWS y N 
F 0 R M A T ( •- R V A W El - ' y F 7 ♦ 2 y ' A V E R A G E D 0 V E R ' y 13 y 2X y ' TRIALS ' ) 
GO TO 9999 
RVDD-AVGY 
R10 H T V E N T RIC IJ L A R DIA S T 0 LIC DIM E N S10 N 
PRINT El03 y RVDD y N 
F0RMAT(' RVDD='»F7,2 y'AVERA0ED OVER'y13 y 2X »'TRIALS') 
GO TO 9999 
SEPD=AVGY 
SEPTAL THICKNESS DURING DIASTOLE 
PRINT 804 y SEED ? M 
F: 0 R M A T ( ' S E P D - ' y F 7,2 r ' A V E R A 0 E D 0 V E R ' y 13 y 2 X y ' T RIA L S ' ) 
GO TO 9999 
SEPS-AVGY 
SEPTAL THICKNESS DURING SYSTOLE 
PRINT SOS y SEES y N 

01010 
01020 
805 
Q 01030 6 
01040 
01050 
C 
G 01060 
01070 
806 
01030 7 
G 01090 
01100 
C 
OHIO 807 
© 01120 
01130 3 
01140 c 
G 01150 
01160 
011 70 
808 
Q 01180 9 
01190 
01200 
C 
© 01210 
01220 
809 
01230 10 
G 01240 C 
01250 % 
01260 310 
© 01270 
01280 11 
01290 C 
© 01300 
01310 
01320 
811 
© 01330 3 2 
01340 C 
01350 
© 01360 312 
01370 
01380 13 
0 01390 
01400 
C 
01410 813 
© 01420 
01430 14 
01440 C 
© 01450 
01460 
01470 
814 
O 01480 15 
01490 
01500 
C 
FORMAT ( ' SEP3-7 ? F7^> 2 r 7 AVERAGED GUER'y 13 y 2X ? 'TRIALS ' ) 
GO TO 9999 
LUES D-AUGY 
LEFT OfNTRI COLOR END SYSTOLIC DIMENSION 
PRINT 806y LUESD y N 
F 0 R M A T ( ' L 0 E S D = ' , F 7.2 y 2 X r ' A V E R A G E D 0 V E R ' y 13,2 X y ' T RIA L S ' 
GO TO 9999 
LVEDD-AVGY 
LEFT UEN'fRICUL..AR END DIASTOLIC DIMENSION 
PRINT 807 y L0EDD >■ N 
F 0 R M A T ( '■ L 0 E D D - ' y F 7 . 2 y 2 X ? ' A 0 E R A 6 E D 0 0 E E ' , 13 y 2 Xy ' T RIA L S ' 
GO Tu 9999 
L.UPWD-AU0Y 
LEFT UENTRICIJLAR POSTERIOR WALL DIAMETER IN DIASTOLE 
PRINT 808 » LUPUD y N 
F 0 R M A T < ' L 0 i::' W D - ' r F 7 * 2 y 2 X, ' A 0 E R A G E D 0 V E R ' v 13 ? 2 X y '_T RIA L S ' . 
GO TO 9999 
LUPU3--AUGY 
LEFT VENTRICULAR POSTERIOR WALL DIAMETER IN SYSTOLE 
PRINT 809*LUPUS*N 
F 0 R M A T ( ' L V P W S =' r F 7.2 ■/ 2 X, ' A V E R A G E D 0 0 E R 7 y 13,2 X ? ' T RIA L S 7 
GO TO 9999 
LAS--AVGY ^ ~ - 
L E Fr T A T RIA L DIM E N S10 N ( M A XIM U M A T S Y S T 0 L E > 
PRINT 810 y LAS y N 
F 0 R M A T ( ' L A S = ' y F 7 * 2 ? 2 X y ' A 0 E R A G E D 0 V E R ' , I3 y 2 X r ' T RI AES') 
GO TO 9999 
AOS-AUGY 
AORTA MEASURED AT SAME PERPENDICULAR AS LAS 
PRINT 811y AOS y N 
E 0 R M A T ( ' A 03-=' ? F 7,2 y 2 X y ' A U E R A G E D 0 U E R 'yI3y 2 Xy'T RIALS') 
GO TO 9999 
PA-AUGY 
PULMONARY ARTERY MEASURED MAXIMALLY AT END SYSTOLE 
PRINT 812 y PA ? N 
F 0 R M A T ( 7 P A = ' y F 7.2 y 2 X y ' A U E R A G E D 0 U E R ' y 13 y 2 X y ' T RIA L 8 ' ) 
GO TO 9999 
MODE-AUGY 
MITRAL VALUE EXCURSION FROM END SYSTOLE Tu DIASTOLE(D-E 
PRINT SI3y MUDE y N 
F 0 R M A T ( ' M U D E = ' y Fr 7.2 y 2 X y ' A U E R A G E D 0 U E R ' y 13 y 2 X r ' T RIA L S') 
GO TO 9999 
TUDE--AUG Y 
T RIC U S PID U A L U E E X C U R S10 N (D - E) 
PRINT 814 y TUDE y N 
FORMAT(' TUDE-7 r F7.2 y 2X y'AVERAGED OUER7 y13 » 2X y 'TRIALS' ) 
GO TO 9999 
LENGTH-1 */AUGY 
STANDARDIZED CORRECTION TO 1 CM 
PRINT 815y LENGTH " ' : 
■ -42- 
. 
c 0151 0 
01520 
815 
01530 16 
© 01540 
01550 
C 
01560 816 
© 01570 
01580 17 
01590 c: 
© 01600 
0.1.610 
01620 
817 
D 01630 18 
016 4 0 
01650 
C 
0 01660 
0.1670 
818 
01680 19 
0 01690 
01700 
C 
01710 819 
© 01720 
01730 20 
01740 C • 
O 01750 
01760 
01770 
320 
*) 01780 21 
01790 
R 
C 
J) 01800 
01810 
01820 
821 
01830 99 
01840 
01850 
C 
0 01860 
01870 
822 
01880 23 
o 01890 
01900 
C 
01910 823 
© 01920 
01930 24 
01940 701 
© 01950 
01960 C 
01970 324 
G 01980 
01990 
02000 
702 
F 0 R M A T ( ' L E N G T H = 7 » F 7 ♦ 2) 
60 TO 9999 
HAFSEC=AVGX 
THIS IS THE CM EQUIVALENT OF HALF A SECOND 
PRINT 8:L 6 y HAFSEC 
FORMAT ( ' HAFSEC-7 ?F7.2) 
GO TO 9999 
L V P E P = A V G X / ( H A F 8 E C X 2 ♦ ) 
LEFT VENTRICULAR PRE EJECTION PERIOD 
PRINT 8:1.7 * LVPE:"P y N 
F 0 R M n T ( ' I... V P E P =' , F 7 ♦ 2 ? 2 X y ' A V E R A G E D 0 V E R' ? 13 ? 2 X ? ' T RIALS 
GO TO 9999 
L V E T = A V G X / (2 ♦ >!-S IA F S E C ) 
L E E T V E N T RIC U L A R E J E C T10 N TI n E 
PRINT 818 y L.VET r N 
F0RM AT ( ' L VET= ' y F7♦2 . ? 2X y ' A VER A GED 0 VER7 ? 13 y 2X y 7 TRIALS ' ) 
GO TO 9999 
R V P E P -• A V G X / ( 2 ♦ * H A F S E C ) 
RIGHT VENTRICULAR PRE EJECTION PERIOD 
PRINT 819? RVPEPyN 
F0RMA T(' RVFE P-,?F7 »2 ?2 X ?/A VERA GED 0V ER/?I3?2X?'TRIALS' 
GO TO 9999' 
R V E T A V G X / ( 2 * # H A F S E C ) 
RIG H T V E N IRIC U L A R E J E C T10 N TIM E 
PRINT 820y RVET? N 
F0RMAT(' RVET =7 ?F7♦2 ?2X?'AVERAGED 0VER'?13 ? 2X?'TRIALS') 
GO TO 9999 
l-l R = 12 0 * * 11A F S E C / A V G X 
HEART RATE: TAKE LENGTH OF MINUTE AND DIVIDE DY LENGTH L 
PRINT 821y HR?N 
F0RM AT ( ' I IR = ' y F7.2 ? 2X ? ' A VER A GED 0 VER' y 13 ? 2 X ? ' TRIALS ' > 
GO TO 9999- - 
MVEF = A VG Y/A VG X12 ♦THA FSEC 
MITRAL VALVE EF SLOPE 
PRINT 822 y MVEF ?N 
FORMAT ( y MVEF--' ? F7.2 ? 2X ? ' AVERAGED OVER ' y 13 ? 2X ? 'TRIALS ' > 
GO TO 9999 
T V E F A V G Y / A V G X12 . >!' H A F S E C 
TRICUSPID VALVE EF SLOPE 
PRINT 823y TVEFfN 
F 0RMA T(' T VE F='? F7.2 y 2X ?'A VERAGED 0VE R'y13 y 2 X y'T RIA L S ' ) 
GO TO 9999 
PRINT 70.1 
FORMAT (' PUT INTO GRAPHICS MODE') 
READ 824y AREA 
THIS IS THE AREA OF THE L.V IN 2 DIMENSIONS FROM REAL TIr 
FORMAT(F9.4) 
PRINT 702yAREA 
F0RMAT ( ' AREA ==' ? F7.2 ? ' RETUF<N GRAPHICS TO p01 NT MODE') 
AREA-AREA#6♦45 

€> 02010 GO TO 700 
• 02020 23 LONGAX - S 0 R T ( A 0 G X ■’< >K 2 . + A 0 G Y * * 2 . ) 
02030 PRINT 706fLONGAX 
© 02040 706 F 0 R M A T < 7 L 0 N G A X = 7 ? F 7 ♦ 2 ) 
02030 C THIS IS THE LONG AXIS ACROSS THE AREA SECTION (REAL Tli 
02060 GO TO 9999 
o 02070 8383 CONTINUE 
02080 C DO COMPUTED VALUES 
02090 LUEDV- -19.12 f 14 * 8 8 >i< L 0 E D D + * 6 2 >!< L_ 0 E D D * * 3 ♦ 
& 02100 LUESU- -19.12 r 14 ♦ 3 3 * I... 0 E S D + ♦ 6 2 X L. 0 E S D * * 3 ♦ 
02110 IF (L y E D D * G E . 2 . ) E F = ( L V E D V - L 0 E S 0 > / L 0 E D 0 
02120 IF(LUEDD♦ L T ♦ 2 . )EF=-69 . 
© 02130 F S = ( L. U E D D -1... 0 E S D ) / L. 0 E D D 
02140 VCF-FS /L..OET 
02180 LPEPET ;:-L_ 0 PE P/LOET 
o 02160 RPEPET -=RUPEIVROET 
02170 LUPEPC =LUPEPi.6*HR 
02180 ROPEPC --F< 0 P E P ■{■ ♦ 5# HR 
o 02190 LUETC- L ViEJ'F 1.6*HR 
02200 RUETC-- RVET41.5*HR 
02210 LAA0~LAS/A03 
o 02220 SPLPWD -SEPD/LOPWD ■ . • 
02230 USDS=T..UPWS/LUESD 
02240 LUCAOP --USDSY228. 
© 02280 SYSGR.D -LOGAOP-BP 
02260 BP=DIA S D P + < S Y S B P - DIA S B P) / 3 
02270 PRINT 707 
o 02280 707 F0RMAT(7 Ti 1 IS IS THE PRINT0UT7////) 
02283 PRINT 161?BSA 
02286 161 FORMAT(7 THE BSA IS7? F5.2) , 
© 02290 PRINT 160 y BP 
02300 PRINT 821yHR 
02310 PRINT 801» ROAWD 
© 02320 PRINT 802 y RVAWS 
02330 PRINT 803?RODD 
02340 PRINT 804?SERB 
o 02330 PRINT 808 y SEP3 
02360 PRINT 806 y LUESEi 
02370 PRINT 807 y L..OEDD 
© .02380 PRINT 808tLOPWD 
02390 PRINT 80?tLUPUS 
02400 PRINT 810vLAS 
© 02410 PRINT 81.1. y AOS 
02420 PRINT 812yPA 
02430 PRINT 8.13 y NODE 
© 02440 PRINT 314 r rODE 
02480 PRINT 817 y LOPEP 
02460 PRINT 810 y LOET ■ • 
© 02470 PRINT 819yROPEP 
02480 PRINT 820 yROE r 
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* $ j f* 
02T 80 PRINT 820 y RVET 
i i ; I.. 
024 90 PRINT 8221MVEF 
02500 PRINT 323 ?TVEF 
i t 02510 PRINT 500 v LVEDV 
3 1 02520 500 F 0 R M A T ( 7 L. 0 E D 0 ( M E Y E R > =7 r F 7 ♦ 2> 
02530 PRINT 501 ? L. VE3V 
! ; 02540 501 F 0 R M A T < 7 L. V E S 0 (ri E Y ER ) = ' y F7 » 2) 
i i 02550 PRINT 502rEF 
02560 502 FORMAT(7 EF~7y F7.2) : 
02570 160 F0RM AT ( 7 HEAN • BP--7 y F6♦1) 
025S0 
02590 
SV^LVEDV-LVESV 
PRINT 550 i SO-* 
02600 5 5 0 F 0 R MA T ( 7 TIIE 8 T R 0 K E 0 0 L Li ME 18 7 y F 8.2 ) 
Q 
02610 
02620 
CU-SVYHR 
PRINT 551 * CO x 
02630 nr nr -| UsJ 1 F0RMAT ( 7 TI IE CARDI AC OUTPUT 18 7 r F9.2) 
02635 CI=CO/BSA 
Q 02636 PRINT 5521Cl 
02637 552 F0RMAT( 7 THE CARDIAC INBEX IS'y F 9 »2 ) - _ 
02640 PRINT 503 ? FS 
O 02650 503 FORMAT(7 fFS=',F7#2) 
02660 
02670 504 
PRINT 504 ?VCF 
F 0 R M A T (/ . 0 CF“ ' ? F 7»2)^ 
.* O 026S0 PRINT 505?LPEPET 
02690 505 FORMATi' LVPEP/ET=7 yF7♦2> 
02700 PRINT 506>RPEPET 
O 02710 506 F 0 FL M A T ( 7 R V p E P / E T = 7 y F 7 ♦ 2 ) 
02720 
02730 515 
PRINT 515yLOPEPC 
FORMAT ( 7 L. VPEF:'C~: 7 y F7♦2) 
o 02740 PRINT 507 •/ ROPEPC 
FORMAT(7 RVPEPC=7 y F7♦2 > ' 02750 507 
, 02760 PRINT 508 * LVETC 
© 02770 503 F0RMAT ( 7 L..0ETC- 7 ? F7♦2) 
027S0 
02790 509 
PRINT 509 yRVETC _ 
F 0 R M A T ( 7 R V E T C = 7 y F 7 ♦ 2 > . 
o 02S00 PRINT 510? LAAO 
02310 510 FORMAT ( 7 L.A/A0 = 7 ? F7*2) 
02820 PRINT 511rSPLPWB 
© 02330 511 Fr 0 R M A T ( 7 8 E P T U M / L 0 F W D = 7 r F 7.2) 
02840 PRINT 512?USDS • - 
i 02S50 512 FORMAT <7 WS/DS™7 y F7♦2) ” 
o 02360 PRINT 513>LOCAOP 
02370 513 F 0 R M A T ( 7 E 8 TIM A TED L 0 C A VITY PRESSURE55 7 * F7 • 2 ) 
02830 PRINT 514 rSYSGRD 
0 02890 514 F0RMAT(7 E8TIMATED SY8T0LIC GRABIENT=7*F7*2) 
02900 C VOLUME CALCULJATIONS ON REAL TIME 
02910 V 0 L ■- 8 . * A R E A Y Y 2 . / ( 3 . Y 3.14 Y L. 0 N G A X) 
o 02920 PRINT 883rVOL 
02930 838 FORMAT (7 THE LV CAVITY VOLUME BY REAL TIME IS 7 ?F7,2> 
02940 STOP 
o 02950 END 
r45- 
' 
o L SUM♦FORT 
SUM,FORT 
1 • 00010 SUBROUTINE SUM 
a 00020 COMMON NfLENGTHy XSTAND»YSTANDr AVGX,AVGYfPfXfY 
00030 INTEGER p 
00040 REAL LENGTH 
r ( 00030 C THIS ROUTINE DEALS WITH AVERAGING LINE SEGMENT VALUES♦ 
00060 C IT HAVDLES SEPARATELY Y INPUTS<P=1) i XINPUTS<P=2>r AND 
00070 C AND COMBINED X AND Y INPUTS(P-3). IT AVERAGES THE 
c 00080 c LINE SEGMENTS AND RETURNS THAT NUMBER AND THE NUMBER OF' 
00090 c TRIALS USED IN THE AVERAGE♦ TO END THE POINT INPUTr 
00100 c MERELY. SELECT A CONTROL GRID? THE PROGRAM RECOGNIZES THAT 
c 00110 p Y IS LESS THAN A AND IT RETURNS THE AVERAGED LINE SEGMENT 
00120 c TO BE EVALUATED^INTHEAPFRQFRIATE WAY, IF A MISTAKE IS 
00130 c MADEf MERELY HIT THE SAME CONTROL GRID AND START AGAIN, 
c 00140 c IF YOU HIT A CONTROL GRIDf YOU MUST REINPUT THAT DATA» 
00150 c FOR THE PREVIOUS DATA FOR THAT GRID WILL BE RESET TO ZERO 
00160 AVGY=0. 
c 00170 AVGX=0♦ 
00180 SUMX1=0♦ 
00190 SUMX2=0, 
c 00200 SUMY1=0, 
00210 SUMY2=0, 
00220 N=0 
0 00230 c DIVIDE UP PROGRAM IN TERMS OF P VALUES 
00240 IF(P-2)81f 82 r 83 
00250 c ENTER FIRST DATA POINT 
0 00260 81 READ 120rXrY 
00270 PRINT 120 f X f Y 
00280 120 FORMAT(F6,2fF7,2) 
0 00290 C SET UP POINT WITH RESPECT TO STANDARD ORIGIN 
00300 X=X-XST AND 
00310 Y=Y-YST AND 
0 00320 C CHECK-IF CONTROL GRID 
00330 IF(Y,LT,4,)GO TO 91 
00340 C MAKE LENGTH CORRECRTl'ON AND CHANGE TO CMS 
0 00350 Y1=Y*2,54YLENGTH 
00360 READ 120 f X y Y 
00370 PRINT 120 y X y Y 
r~- 00380 X=X-XST AND 
00390 Y=Y-YSTAND 
00400 IF(Y,LT,4,)GO TO 91 
0 00410 Y2=Y*2.54>KLENGTH 
00420 C SET THE COUNTER FOR THE NUMBER OF TRIALS 
' 00430 N = N f 1 
r\ 00440 C ADD THE Y VALUES FOR AVERAGING 
00450 SUMY 1 =SIJMY 1 -{-Y1 
00460 SUMY2=SUMY2+Y2 
r\ 00470 GO TO 81 
00480 91 IF (N. EQ ♦ 0 ) RETURN _  _.... 

004 90 
00500 
00510 
C RETURN IF N~0 BEICOUSE' THIS MEANS A CONTROL GRID UAS SELECT 
AOGY-ABS(SUMY2-SUMY1)/N 
RETURN 
00520 C THIS IS FOR F’=2 
00530 82 READ 120,X,Y 
00540 PRINT 12 0,X,Y 
00550 X ~ X - X S T A N D 
00560 Y=Y~YSTAND 
00570 IF < Y 4 LT♦4 4)GO TO 92 
00580 X1---XT2,54 
00590 READ 120,X,Y 
00600 
00610 
00620 
00630 
00660 
00650 
00660 
00670 
00680 
00690 92 
00700 
00710 
00720 C 
00730 83 
00740 
00750 
00760 
00770 
00780 
00790 
00800 
00810 
PRINT 120.X,Y 
X=X~XST4ND 
Y=Y-YSTAND 
IF < Y ♦ l.T ♦ 4 ♦ ) GO Ta 92 
X2=X*2.54 
N-Nf 1 
SUMXi=SUMX1+X1 
SUMX2 = SlJMX2-f X2 
GO TO 82 
IFtN.EG.O) RETURN____ 
AUGX-ABS < SUMX2-SUMX1) /N 
RETURN 
DO THE SAME fOR P=3 (X AND Y CONSIDERED TOGETHER) 
R E A D 120 ?X tY 
.PRINT 120,X,Y 
X-X--XST AND 
Y~Y“YSTAND 
IF (Y. L.T, 4, ) GO TO 93 
X1=X*2.54 
Y1 ~ Y £ 2 4 54 * L E N G TH 
READ 120,X,Y 
PRINT 12 0,X,Y 
00820 
00830 
00840 
X-X-XST AND 
Y=Y-YSTAND 
IF(Y 4 LT 4 4 4) GO TO 93 
00850 
00860 
00870 
X2=X#24 54 
Y2=Y#2 * 54&LENGTH 
N=N+1 
00880 SUMX1 = SUMX .1 TX1 
00890 SUMX2~SUMX2iX2 
00900 SUMY1~-SUMY1+Y1 
00910 SUMY2-SUMY2+Y2 
00920 GO TO 83 
00930 93 IF (N ♦ EiO * 0 ) RETURN 
00940 AUGX-(SUMX2-SUMX1)/N 
00950 AVGY=(SUMY2-SUMY1)/N 
00960 RETURN 
00970 END 
READY 

o 
EDIT 
L. 
00010 
00020 
00060 
00070 
SIJ B E 0 U TIN E D L. G 0 D ( X S T A N D y Y S T A N D t S Y S B P y DIA S B P ) 
IN T E G E R N E W X < 3 > y B P (2 ) y S Y S B P y DIA S B P 
BF:' (1 ) =0 
BP < 2 ) =:0 
00080 PRINT 100 
Q 00090 100 F0RMA T< 7 RE A D IN SY3 T 0 LX C BP7) 
00100 L”1 
00110 7 NEWX<1>~0 
o 00120 NEWX ( 2 ) =•••• 0 
'00130 NEWX<3)=0 
00131 *0 8 N~ I y 3 
G 00132 READ 10.1. yXyY 
00133 PRINT 10.1 ? Y 
00140 101 FORMAT (F‘6 ♦ 2 ? F7 ♦ 2) 
0 00130 NEWY=Y-YSTAND 
00160 IF<NEWY«GT*1)N=N-1 
00170 IF(NEWY.GT»1)G0 TO 17 
o 00180 N E W X ( N) = X ~ X S 7 A N D --1 
00190 8 CONTINUE 
00200 17 NMl-N-l 
G 00210 NM2-N-2 
00220 IF" C N -• 2)3? 4 y 5 
00230 3 NM1 -3 
O 002 4 Q 4 NM2-3 
00250 5 BP (L.) -NEWX ( N ) -f NEWX (NM1) Y1OTNEWX ( NM2 ) Y100 
00260 IF(L♦EQ*2)00 TO 19 
C: 00270 PRINT 102 
00280 102 FORMA 1' ( 7 READ IN DIASTOLIC DP7) 
00290 L--2 
o 00300 GO TO 7 
00310 19 SYSBP-BP(1) 
00320 BIASBP=BP<2) 
c 00330 P RIN T .10 3 y S Y S B P A) IAS B P 
00340 103 FORMAT(14y14) 
00350 RETURN 
c 00360 END 
END OF DATA 
o 
o 
o 
o 
o 

READY 
L 
( 
( ENTER DATA SET NAME - 
BODY♦FORT 
f BODY ♦ FORT 
OOOIO S U B R 0 U TIN E B 0 D Y < X S T A N D y Y 8 T A N D y B S A ) 
00020 INTEGER NUM(3) 
/ V 00030 NUM(1)-0 
00040 NIJM (2*) --0 
00050 NUM(3)-0 
c 00060 PRINT 100 
00070 100 F 0 R M A T < / R E A D IN B 0 D Y S U R F A C E A R E A ' ) 
00080 DO 28 N~193 
c 00100 READ 101r X r Y 
00110 PRINT 101y X y Y 
00120 101 FORMAT(F6♦2? F7♦2) 
c 00130 NEIJY-'Y-YS f AND 
00140 NEWX-X-XSTAND 
00160 IF (NEWY♦GT * 1♦AND,NEUX *EQ♦5 > G0 TO 17 
r 00170 28 ♦ N LI M ( N ) N E W Xc-1 
00180 17 BSA=NUM < 1 ) + ♦ 1 *NUn (2)1,01 >!<NLJM ( 3) 
00190 % PRINT 103 ? BSA 
c 00200 103 FORMAT <F5♦2) 
00210 RETURN 
00220 END 
c. READY 



c 
c 
c 
c. 
c 
c 
c 
c 
c 
c 
o’ 
c 
c 
c 
o 
c 
EXEC M 
INPUT POINTS 
+01.51 +02.74 
1.51 
+06.16 
6.16 
+04.84 
4.84 
+04.83 
4.83 
+07.12 
'7,12 
LENGTH" 
+05,04 
5,04 
+ 06»03 
6.03 
+02.11 
2.11 
2,74 
+04.13 
4,13 
+07.51 
7,51 
+07,18 
7.18 
+04.23 
4,23 
1.19 
+06.98 
6,98 
+06♦£5 
6 T 95 
+05.32 
HAF S E C - 2,5 
+03 . 05 + 07 ,02 
3. 05 7. 02 
+ 04 ,70 + 06 -o
 
CD
 
4. 70 6« 98 
+04 ,80 +06 .98 
4, 80 6 ♦ 98 
+ 06 .36 + 06 ,95 
6. 36 6, 95 
+ 06 .36 + 06 . 95 
6. 36 6. 95 
+ 07 .60 + 06 .93 
7. 60 6 ♦ 93 
+ 07 ,99 + 03 . 15 
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■ 7,01 
© LVC£i:iD — 
+07.03 
0 7.03 7*63 
- +07*24+06.88 
Q 7.24 6.88 
+ 07.32 + 07 4 63 
: 0 7*32 
+07.58 
© 7.58 
j +07.69 
© 7.69 7.62 
+07♦74 +06.92 
© 7.74 6.92 
+08.01 +05.29 
- - - # -. _ 
0 3.01 5.29 
L0ESD- 2*. 21 AVERAGED GOER 
REAB IN SYSTOLIC BP 
• © +03.02 +03.12 
3.02 3♦12 
© +04.06 +03.21 
- 4.06 3.21 
0 +02.07 +03.28 
2.07 3.23 
© READ IN DIASTOLIC BP 
+10.07 +03.12 
7.63 
+06.94 
6.94 
+07.62 
3.22 
4.15 A 0 E R A G E D C) 0 E R 3 T RIA L. S 
+07.68 
0 10.07 3.12 
+02.11 +03.33 
0 2.11 3.33 
+10.03 +05.17 
© 10.03 5.17 
120 80 
+08.99 +05.13 
I 
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8.99 5.13 
READ IN BODY SURFACE AREA 
•103.12 103.18 
3.12 3.18 
•107.98 +03.14 
7.98 3.14 
+01.99 +03.26 
1.99 3.26 
1.60 
+07.09 +05.16 
7.09 5.16 
THIS IS THE PRINTOUT 
Q 
THE BSA IS 
MEAN BP~ 
IIR-- 80.09 
LVESD-- 3,21 
L.VEDD- 4.15 
L..VEDV ( MEYER > = 
LOESO(MEYER)= 
EF= 0.77 
THE STROKE 00LOME IS 
CARDIAC OUTPUT IS 
CARDIAC INDEX IS 
THE 
THE 
1.60 
3.0 
AVERAGED OVER 
AVERAGED OVER 
AVERAGED OVER 
85.77 
19.84 
65.93 
5280.05 
3300.03 
READY 
© 

Appendix B 
Protocol for Etomidate Study 
54 - 

SUMMARY 
In modern anesthesia, apart from the requirements of freedom 
from pain, muscle relaxation, and cardiovascular and respiratory 
stability and control, growing importance is placed on 
making the experience of anesthesia as comfortable as possible 
for the patient. Rapid and pleasant induction may be all 
that matters to the patient. But the safety of the agents 
used should be the first concern of the anesthesiologists. 
Although the available induction hypnotics are often far 
from harmless for the cardiovascular system, most anesthesiologists 
have obviously highly valued the advantage of rapid onset of 
sleep. 
The pharmacological profile of etomidate, a pure hypnotic of 
high potency, and short duration with a wide safety margin 
and minimum effect on the cardiovascular and respiratory 
systems and which causes no release of histamine and no 
known organ toxicity or biochemical and hematological changes, 
suggests that it might be of value for the induction of 
anes thesia. 
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I. Background 
-2- 
AIM: To observe the effects of c-tcmidate and thiopental 
on the cardiovascular system in surgical patients. 
PHASE: Efficacy and Safety--Phase III 
MEETING WITH FDA: Not applicable. 
II. Objectives 
To determine whether etomidate offers cardiovascular 
advantages over thiopental in surgical patients. 
III. Investigators 
A. Principal Investigator 
Paul G. Barash, M.D. 
Department of Anesthesiology 
Yale University Hospital 
School of Medicine 
333 Cedar Street 
New Haven, Connecticut 06510 
B. Co-Investigators 
Charles Klcinman, M.D. 
Susan Firestone, M.D. 
Cayctano Dizon, M.D. 
Charles Kopriva, M.D. 
Department of Anesthesiology 
Yale University Hospital 
School of Medicine 
333 Cedar Street 
New Haven, Connecticut 06510 
C. Clinical Facilities 
The clinical facilities and laboratories of the 
Yale University School of Medic a nc- will be employed 
in this study. 
D. Ins t.i tutiona 1 Review 
The Research Committee of Yale University will 
review and approve this protocol and record form 
before any work is started. 
E. Informed Patient Consent 
Written informed patient consent will be obtained 
from all patients before entering this study. 
IV. Experimental Plans 
A. Patients 
Characterization of the study group 
The study will c o n s r s 
1. 

-3- 
2. Source.; of patients 
A3. 1 .uirgica] patients of the Yale University . - 
New Haven Hospital may participate in this 
study. 
3. Criteria for inclusion or exclusion of patients 
This study will consist of 40 patients (male and/or 
female) who are candidates for intravenous induction 
of general anesthesia. All surgical patients described 
as physical status 1, 2, 3, or 4, definition adopted 
by the American Society of Anesthesiologists, will be 
acceptable for this study. 
All patients scheduled for emergency surgery, females 
of child bearing potential and patients under 1C 
years of age will be excluded. 
4. Concurrent medications 
All concurrent medications will be continued in 
the peri-operative period as clinically indicated. 
B. Procedure 
1. Experimental drug 
Etomidate 2 mg in a vehicle consisting of 
propylene glycol 355 (v/v) in sterile water for 
injection. 
Batch numbers - not assigned to date. 
Etomidate injectable 2 mg per ml for intravenous 
administration will be supplied by Janssen 
R & D, Inc., 501 George Street, New Brunswick, 
New Jersey 08903 
2. Control drug - Thiopental 
3. Type of control 
Alternating assignment with control drug 
4. Treatment plan (see flow chart, page 8, and schematic 
page 9) 
a.. Following agreement by the attending anesthesiologist, 
surgeon, and anesthetic evaluation, the patient will 
be told of the purpose of the study. If he/she agrees 
to participate, a consent form will be signed. 
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b. Preopcrative cardiovascular evaluation will 
include routine measurements of blood pressure 
an 1 pulse. 
Approximately 60-90 minutes following premedication, 
which will be: Morphine sulfate 0.1-0.2 mg/kg 
and scopolamine .006 mg/kg; another set of 
hemodynamic measurements will be obtained. 
c. Anesthesia will then be induced with either 
thiopental 4 mg/kg or etomidate 0.3 mg/kg. 
Alternate patients will be used for each drug 
(see allocation table, pages 10-12). If in 
the opinion of the investigator the patient 
regains consciousness, additional doses of 
hypnotic may be given. These doses will be 
one-half the initial dose. 
d. Rate and site of the injection will be the 
same for both of the hypnotics, and will be 
left to the investigator's discretion. The 
hypnotics will be administered through an I.V. 
line in a peripheral vein. The rate and site 
of the injection will be recorded. An injection 
' over 60 seconds in a large vein is recommended. 
e. Following loss of consciousness, the patient 
will be maintained on nitrous oxide/oxygen 
60/40 as is customary. Hemodynamic measurements 
will be made for three minutes. At 3 minutes, 
10 cc's of blood will be drawn for determination 
of drug levels. 
f. Adequate ventilation will be assured by clinical 
observations and measurement of end-tidal gas 
samples from the anesthesia circuit. 
g. The investigators will also correlate other 
hemodynamic data obtained from patients who 
clinically require more extensive monitoring 
(e.g., arterial catheter, Swan-Ganz catheter)- 
If arterial catheters have been placed, a control 
and three minute arterial blood gas will be 
obtained. 
h. Further echocardiographic measurements during 
the perioperative period will be made if 
warranted. 
i. Doctor's standard choice of postoperative 
antiemetics and/or analgesics, etc., wri 11 be 
employed. 
The record form to be used is attached. 
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5. 
-b- 
Clinical observations 
a. Entry requirements: See IV A. 2. Source of 
patients. 
b. Critical basic measurements in final analysis: 
Measurements 
1. Pulse Rate 
2. Arterial pressure, systolic and diastolic 
3. Heart rate and rhythm 
4. Echocardiogram 
5. Central Venous Pressure 
6. Pulmonary artery Pressure, systolic and diastolic 
7. Pulmonary V7edge Pressure 
8. Cardiac output (Thermal dilution) 
where clinically indicated for patient care. 
c. Derived hemodynamic profile may include: 
1. Cardiac Index 
2. Stroke Index 
3. Left Ventricular stroke work index 
4. Pulmonary Vascular resistance 
5. Total peripheral vascular resistance 
6. Left Ventricular end diastolic volume 
7. Ejection Fraction 
8. Velocity of Circumferential fiber shortening 
9. Systolic time intervals 
6. Metabolic studies 
Arterial blood gas values will be determined pre- 
and posthypnotic. (See Section IV, B, 4g). 
7. If any serious adverse effects should occur, the 
patient will be removed from the study and the 
condition treated promptly. All side effects must 
be recorded on the case record form. 
If any severe or unusual reactions occur, please 
immediately call Dr. Jc Brugmans or Mr. Steven 
Schlossbcrg at (201) 524-9741 of Janssen R & D, Inc., 
New Brunswick, New Jersey 08903. If no reply, please 
call (201) 524-0400, a 24-hour emergency number. 
8. Conditions and procedures for removing a patient 
from the study 
Any severe or life-threatening event will be sufficient 
to remove a patient from the study 
9. Conditions for terminating or extending the entire 
study 
The entire study may be terminated if an unusual 
number of adverse reactions occur by notifying the 
sponsor. The study may be extended if deemed 
necessary by the investigator only with the mutual 
r—^s.'nh of fh,' c-nr.n'-.ov 
' 
- O “ 
10. Analysis of data 
At completion of the study, it is expected that 
data will be available on the following points in 
particular: Hemodynamic cardiovascular measurements 
and calculations for both hypnotics both prior to 
administration and up to three minutes after 
the cidministration of the hypnotics. 
11. Radioactivity specifications - Not applicable. 
V. Monitoring and Data Processing 
A. Monitors - Janssen R & D, Inc., New Brunswick, New 
Jersey 08903 
J. Wm. D. Cornett, M.D. Steven Schlossberg 
Med. Res. Consultant Project Monitor 
Jo Brugmans, M.D. 
Vice Pres, and Gen. Mgr. Clinical Research Assistant 
Roger L. Aspeling 
Director of Clin. Res. 
B. Statistician « 
Mr. J. Dony 
C. Execution 
1. Estimated timetable 
The duration of the study is estimated at not 
more than four months. 
2. Checks and controls of clinical data collection 
All f orms will be checked by the principal monitor 
and statistician. .Any possible inaccuracy on the 
anesthesiologist's form will be checked with the 
investigator. 
3. Data processing procedures 
All data from the record forms will be first tran¬ 
scribed to computer input records, then punched 
and repunched for control. All pertinent and rele¬ 
vant delta will be finally summarized in tables. 
4. .Data processing checks and controls 
Not applicable 
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5. Incidence of transcribing errors 
Transcribing errors v.’ili be kept to a minimum 
since all record forms will be transcribed by 
a well-trained and qualified statistician. A 
random test will be done by the principal 
statistician in order to check transcribing 
'accuracy. 
Missing values in the data will be kept to a 
minimum as the studies will be conducted by 
well-qualified investigators and properly 
monitored by well-trained Clinical Research 
Associates. 

-8 - 
ETOMIDATE STUDY FLOW CHART 
BEFORE 
HYPNOTIC 
1. Select patient who meets acceptance criteria. 
2. Administer premedication according to protocol. 
3. Hemodynamic measurements immediately prior to 
hypnotic. 
DURING 
HYPNOTIC 
4. Administer hypnotic as shown in allocation 
chart. 
AFTER 
HYPNOTIC 
5. At one minute intervals up to 3 minutes after 
administration of hypnotics, perform hemodynamic 
measurements and record results. 
G. Continue with further induction (intubation, 
muscle relaxants, analgesics, etc.) 
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